XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   116,768     116,768  
Beginning balance $ 1,429,994 $ 1,418,697 $ 1,381,388 $ 1,353,422 $ 1,418,697 $ 1,353,422
Net income 126,251 92,904 97,316 114,891 $ 219,155 212,207
Foreign currency adjustments (1,313) (19,490) (6,536) 2,477    
Dividends declared (74,006) (74,065) (73,577) (73,581)    
Stock issued for employee benefit plans 9,943 (10,725) 15,206 (375)    
Stock-based compensation expense $ 19,572 22,673 6,035 15,607    
Repurchase of common stock     (31,725) (31,053)    
Ending balance (in shares) 117,262       117,262  
Ending balance $ 1,510,441 $ 1,429,994 $ 1,388,107 $ 1,381,388 $ 1,510,441 $ 1,388,107
Dividends declared, per share (in dollars per share) $ 0.61 $ 0.61 $ 0.61 $ 0.61    
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares) 117,000 116,768 116,437 116,323 116,768 116,323
Beginning balance $ 11,700 $ 11,677 $ 11,644 $ 11,632 $ 11,677 $ 11,632
Stock issued for employee benefit plans (in shares) 262 232 228 430    
Stock issued for employee benefit plans $ 26 $ 23 $ 22 $ 44    
Stock-based compensation expense (in shares) 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares)     (330) (316)    
Repurchase of common stock     $ (33) $ (32)    
Ending balance (in shares) 117,262 117,000 116,335 116,437 117,262 116,335
Ending balance $ 11,726 $ 11,700 $ 11,633 $ 11,644 $ 11,726 $ 11,633
Additional Paid-in Capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 746,998 754,093 730,363 743,288 754,093 743,288
Stock issued for employee benefit plans (10,435) (29,768) (2,154) (28,532)    
Stock-based compensation expense 19,572 22,673 6,035 15,607    
Ending balance 756,135 746,998 734,244 730,363 756,135 734,244
Retained Earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 5,639,629 5,620,790 5,631,750 5,590,440 5,620,790 5,590,440
Net income 126,251 92,904 97,316 114,891    
Dividends declared (74,006) (74,065) (73,577) (73,581)    
Ending balance 5,691,874 5,639,629 5,655,489 5,631,750 5,691,874 5,655,489
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (100,436) (80,946) (86,383) (88,860) (80,946) (88,860)
Foreign currency adjustments (1,313) (19,490) (6,536) 2,477    
Ending balance (101,749) (100,436) (92,919) (86,383) (101,749) (92,919)
Treasury Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (4,867,897) (4,886,917) (4,905,986) (4,903,078) (4,886,917) (4,903,078)
Stock issued for employee benefit plans 20,352 19,020 17,338 28,113    
Stock-based compensation expense 0 0 0 0    
Repurchase of common stock     (31,692) (31,021)    
Ending balance $ (4,847,545) $ (4,867,897) $ (4,920,340) $ (4,905,986) $ (4,847,545) $ (4,920,340)